Charles A. Simonton, III, MD

Original Contribution

Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial

08/01/2021

Paul Guedeney , MD;

Joseph F. Sabik III, MD;

Charles A. Simonton III, MD;

Zixuan Zhang , MS;

Ovidiu Dressler , MD;

Arie Pieter Kappetein , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Patrick W. Serruys , MD, PhD;

David E. Kandzari , MD;

Marie-Claude Morice , MD, FESC, FACC;

Roxana Mehran , MD;

Toshiki Kuno , MD, PhD;

Ori Ben-Yehuda , MD;

Bimmer E.P.M. Claessen , MD, PhD;

The study objective is to assess the safety and efficacy of using vascular closure devices in percutaneous coronary intervention for left main coronary artery disease.

The study objective is to assess...

08/01/2021

Journal of Invasive Cardiology

AngioJet Experience from the Multi-Center STENT Registry

08/01/2008

John Cedarholm , MD;

Angela Humphrey ;

Sherry Laurent , PhD;

Charles A. Simonton III, MD;

Bruce R. Brodie , MD;

Michael J. Rinaldi , MD, FACC, FSCAI;

Hadley Wilson , MD;

Robert Haber , MD;

Glen Kowalchuk , MD;

In order to explore the use of AngioJet rheolytic thrombectomy in general clinical practice, the database of the Strategic Transcatheter Evaluation of New Therapies (STENT) Registry was used to assess both the utilization and clinical...

In order to explore the use of...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Clinical Experience with a Circumferential Clip-Based Vascular Closure Device in Diagnostic Catheterization

08/01/2008

Carol Anne Yarbrough , RN;

Michael Zapien ;

Charles A. Simonton III, MD;

Louis Cannon , MD, FACC, FACP;

Daniel T. Lee , MD;

Michael R. Mooney , MD;

James B. Hermiller , MD, FACC, FSCAI;

Tony M. Chou , MD;

Tomoaki Hinohara , MD;

Harold Carlson , MD;

Charles O'Shaughnessy , MD;

Richard Fortuna , MD, PhD;

Approximately 7 million angiograms and interventional procedures are performed worldwide each year, and the incidence of these procedures continues to rise, particularly in developing countries. The vast majority of these procedures are...

Approximately 7 million...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Preclinical Evaluation of Second-Generation Everolimus- and Zotarolimus-Eluting Coronary Stents

07/30/2013

Saami K. Yazdani , PhD;

Alexander Sheehy ;

Marc Vorpahl , MD;

Masataka Nakano , MD;

Fumiyuki Otsuka , MD, PhD;

Gaku Nakazawa , MD;

Charles A. Simonton III, MD;

Rosy S. Donn ;

Laura E. Perkins , DVM, PhD;

Renu Virmani , MD, PhD;

Frank D. Kolodgie , PhD;

Second-generation DES have alleviated the safety concerns of late stent thrombosis by addressing issues of polymer biocompatibility, stent design and optimizing drug loads and release kinetics. This study was designed to evaluate the...

Second-generation DES have...

07/30/2013

Journal of Invasive Cardiology

Technology Pulse

The Frontrunner CTO Catheter Experience

06/19/2008

Charles A. Simonton III, MD;

Dennis R. Chadwick , RCIS, BS, FSICP;

Although the treatment of CTOs via conventional percutaneous intervention is a well-established modality with reasonably predictable results, the failure to cross using conventional guidewire technology frequently precludes subsequent repair...

Although the treatment of CTOs...

06/19/2008

Cath Lab Digest